3Kwok A, Lain T, Katelaris P,et al. Helicobacter pylori eradication therapy : Indications, efficacy and safety [ J ]. Expert Opin Drug Saf, 2005,7 (3) :271 -281. 被引量：1
4NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease[J].JAMA,1994,272(1):65-69. 被引量：1
5Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma., results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group[J]. Gastroenterology, 2000,119(5) .. 1191 -1202. 被引量：1
6Fischbach W, Goebeler-Kolve ME, Dragosics B, et al Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue(MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series[J]. Gut, 2004,53(1): 34-37. 被引量：1
7Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple firstline therapies for Helicobacter pylori[J].Aliment Pharmacol Ther, 2007,26(3): 343-357. 被引量：1
8De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study[J]. Dig Liver Dis, 2001,33(8) :676-679. 被引量：1
9Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment[J].Aliment Pharmacol Ther,2003,17(5):719-726. 被引量：1
10FrancavilIa R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial[J].Gastroenterology, 2005,129(5) : 1414-1419. 被引量：1
